Asian Spectator

Times Advertising

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Aksi seksisme di ruang digital memiliki pola tersendiri yang bisa kita pahami

Seksime di internet sering kali dianggap sepele karena dianggap sekadar komentar-komentar buruk maupun lelucon yang kasar yang sayangnya kerap dimaklumi sebagai candaan semata. Namun, apa yang tampakn...

Bukan hanya pemilik mobil mewah, dampak kenaikan harga BBM nonsubsidi bakal dirasakan semua orang

● Para pengguna pertamax turbo dan solar nonsubsidi harus gigit jari karena kenaikan harganya sangat tinggi.● Kenaikan harga ini seolah hanya berdampak pada kalangan menengah ke atas.χ...

Cuma ‘nyuci-ngepel’: Bagaimana bias gender melanggengkan eksploitasi PRT di Indonesia

Aksi protes mendukung pengesahan UU PPRT di depan gedung DPR RI(Bagus upc/Shutterstock)● Kelas menengah Indonesia amat tergantung pada pekerja rumah tangga untuk mendukung produktivitas.● ...